By A Mystery Man Writer
Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation
Watchman, Amulet LAAO Devices Have Similar Leak Rates at About 1 Year
Current Endocardial Approaches for LAA Closure – touchCARDIO
Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross Line Extension Compatible with Watchman Delivery System
Different Strengths for LAA Closure Devices?
TCT 2021: SWISS-APERO trial finds lower rate of peri-device leak in Amulet compared to Watchman FLX LAAC device - Cardiovascular News
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
TCT DAIC
Frontiers Left atrial appendage exclusion in atrial fibrillation
Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure)
Abbott's Amulet gives Watchman a run for its money in head-to-head trial, 2021-08-31
Current and Future Perspectives on LAAO
First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes
Transcatheter LAA Closure Transcatheter Left Atrial Appendage Closure